Hospital
Hca Healthone LLC
Hca Healthone LLC was paid $13.35M by Medicaid between Jan 2018 and Dec 2024, across 101 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.
33Billing provider infoHCA HEALTHONE LLC
DENVER, CO 80218
DENVER, CO 80218
33aNPI1720038946assigned 05/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.35M
24GClaims283,413
24DCodes billed101
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#11 of 51
Median peer was paid$1.24M
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,872 | $1.64M | |
| 2019 | 43,628 | $1.93M | |
| 2020 | 32,464 | $1.29M | |
| 2021 | 37,804 | $1.47M | |
| 2022 | 45,650 | $2.42M | |
| 2023 | 45,557 | $2.45M | |
| 2024incomplete | 39,438 | $2.16M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 42% | 41,691 | 38,210 | $5.63M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 33,390 | 29,373 | $4.10M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.5% | 6,799 | 6,402 | $1000K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.7% | 1,763 | 1,488 | $495K |
| 80053 | Comprehensive metabolic panel | 3.4% | 29,512 | 23,615 | $451K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 2.0% | 203 | 195 | $266K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.3% | 976 | 413 | $179K |
| 80197 | <1% | 4,212 | 2,246 | $125K | |
| 95782 | <1% | 142 | 135 | $123K | |
| 84484 | <1% | 5,652 | 4,316 | $95K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 417 | 383 | $84K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 452 | 441 | $70K |
89 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,822 | $70K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 902 | $65K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 355 | $63K |
| 81001 | <1% | 15,889 | $53K | |
| 85027 | <1% | 40,027 | $46K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 55 | $45K |
| 30140 | <1% | 12 | $34K | |
| 83735 | <1% | 5,147 | $32K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 449 | $29K |
| 31622 | <1% | 69 | $28K | |
| 87496 | <1% | 946 | $27K | |
| 80069 | <1% | 814 | $26K | |
| 76770 | <1% | 169 | $26K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,098 | $20K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 14 | $19K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 261 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 226 | $14K |
| 85610 | <1% | 3,906 | $14K | |
| 80320 | <1% | 121 | $12K | |
| 82570 | <1% | 2,148 | $11K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,324 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16,098 | $8K |
| 96112 | <1% | 18 | $7K | |
| 82977 | <1% | 4,399 | $7K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,967 | $7K |
| 99285 | Emergency room visit (most serious) | <1% | 57 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 106 | $4K |
| 82105 | <1% | 101 | $4K | |
| 83970 | <1% | 201 | $4K | |
| 84100 | <1% | 5,019 | $3K | |
| 84156 | <1% | 2,097 | $3K | |
| 74170 | <1% | 18 | $3K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,725 | $2K |
| 42975 | <1% | 25 | $2K | |
| 82728 | <1% | 121 | $2K | |
| 11043 | <1% | 25 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,796 | $1K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 922 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $1K |
| 83540 | <1% | 125 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,427 | $858.41 |
| 82043 | <1% | 13 | $794.72 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 616 | $710.29 |
| 83550 | <1% | 124 | $685.18 | |
| 83880 | <1% | 13 | $653.30 | |
| 83615 | <1% | 335 | $544.06 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,091 | $491.48 |
| G0378 | Hospital observation service, per hour | <1% | 39 | $478.79 |
| Q3014 | Telehealth originating site facility fee | <1% | 105 | $348.13 |
| 84550 | <1% | 293 | $208.05 | |
| 80076 | <1% | 13 | $187.09 | |
| 82077 | <1% | 1,805 | $151.40 | |
| 82465 | <1% | 134 | $143.22 | |
| 81003 | <1% | 116 | $122.01 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,207 | $85.48 |
| 85730 | <1% | 45 | $79.52 | |
| 83690 | <1% | 6,065 | $78.08 | |
| 82040 | <1% | 13 | $56.36 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 799 | $54.24 |
| 84703 | <1% | 4,902 | $22.80 | |
| 84702 | <1% | 375 | $11.20 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 3,400 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 977 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 14 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 429 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 126 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 801 | $0.00 |
| 80306 | 0% | 178 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 12 | $0.00 |
| 74018 | 0% | 152 | $0.00 | |
| 81025 | 0% | 131 | $0.00 | |
| 82075 | 0% | 144 | $0.00 | |
| 82248 | 0% | 42 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 100 | $0.00 |
| 96113 | 0% | 18 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 15 | $0.00 |
| 88304 | 0% | 159 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 516 | $0.00 |
| 87081 | 0% | 394 | $0.00 | |
| 87430 | 0% | 781 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 273 | $0.00 |
| 86140 | 0% | 188 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 27 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 14 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 90 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 51 | $0.00 |
| 83605 | 0% | 30 | $0.00 | |
| 86780 | 0% | 13 | $0.00 | |
| 85379 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSENSING, PHILLIP (CFO)